Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-28.05	61.60	85.61
Graham Fair Price	-19.71	1777.75	2214.09
PEG	64.55	-0.42	0.25
Price/Book	0.64	1.67	1.66
Price/Cash Flow	10.85	-71.43	-80.13
Prices/Earnings	54.13	68.64	-44.53
Price/Sales	-7.96	5.93	6.44
Price/FCF	10.85	-71.43	-80.13
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	29.26	0.24	0.19
Operating Margin	529.96	0.05	< 0.005
ROA	-36.07	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-34.71
ROIC	< 0.005	< 0.005	761.49
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	0.02	30.81
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.90	5.84	545.98
EPS QOQ	-1.76	1.65	-6.33
FCF QOQ	-3.84	-0.12	96.83
Revenue QOQ	-0.05	0.09	57.95
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	28.55	28.95	1.38
Days Sales Outstanding (DSO)	46.38	46.48	0.22
Inventory Turnover	3.15	3.11	-1.36
Debt/Capitalization	0.41	0.42	2.01
Quick Ratio	0.37	0.37	-0.36
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4839.32	4808.76	-0.63
Cash	559.12	532.01	-4.85
Capex	-128.68	-179.10	-39.18
Free Cash Flow	-100.09	-112.27	-12.17
Revenue	1245.28	1352.99	8.65
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.47	0.47	-0.15
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	23.14	17.29	-25.27
Naive Interpretation	Member

06 - Financial Health · Bad

Rating